• Explore /
  • Poster
  • / Seven-year overall survival analysis from ECHELON-1 study of A+AVD versus ABVD in patients with previously untreated stage III/IV classical Hodgkin lymphoma.

Seven-year overall survival analysis from ECHELON-1 study of A+AVD versus ABVD in patients with previously untreated stage III/IV classical Hodgkin lymphoma.

Abstract Video & Slides Poster

Authors

null

Stephen M. Ansell

Division of Hematology, Mayo Clinic, Rochester, MN

Stephen M. Ansell , David J. Straus , Joseph M. Connors , Wojciech Jurczak , Won-Seog Kim , Andrea Gallamini , Radhakrishnan Ramchandren , Jonathan W. Friedberg , Ranjana H. Advani , Martin Hutchings , Andrew M. Evens , Kerry J. Savage , Hyeon-Seok Eom , Tatyana A Feldman , Jeremy S. Abramson , Cassie Dong , Bipin N. Savani , Athanasios Zomas , Keenan Fenton , John Radford

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Track

Hematologic Malignancies

Sub Track

Hodgkin Lymphoma

Clinical Trial Registration Number

NCT01712490

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 7053)

DOI

10.1200/JCO.2024.42.16_suppl.7053

Abstract #

7053

Poster Bd #

36

Abstract Disclosures

Similar Posters

First Author: Howland E. Crosswell

First Author: Stephen Maxted Ansell

First Author: Anas Younes

First Author: Scott F. Huntington